AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Amoxycillin Sodium Equivalent To Amoxycillin

11 registrations across 1 African market— 8 active

Markets with Amoxycillin Sodium Equivalent To Amoxycillin

Recent registrations

Brand / ProductMarketHolderStatusExpires
CURAM 1,2 G 20 ML🇿🇦South AfricaSandoz South Africa (Pty) LtdsuspendedAug 2025
CURAM 0,6 G 20 ML🇿🇦South AfricaSandoz South Africa (Pty) LtdsuspendedAug 2025
AUGMAXCIL INJECTION🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedNov 2022
RUBICLAV 0,6🇿🇦South AfricaGulf Drug Company (Pty) LtdactiveSept 2021
RUBICLAV 1,2🇿🇦South AfricaGulf Drug Company (Pty) LtdactiveSept 2021
CLAmgEN IV 1,2🇿🇦South AfricaViatris South Africa (Pty) LtdactiveJan 1900
CLAmgEN IV 0,6🇿🇦South AfricaViatris South Africa (Pty) LtdactiveJan 1900
AMOXY CO 500/100 GDC🇿🇦South AfricaGulf Drug Company (Pty) LtdactiveJan 1900
AMOXY CO 1 000/200 GDC🇿🇦South AfricaGulf Drug Company (Pty) LtdactiveJan 1900
SANDOZ-AMOCLAV 1,2 g 20 ml🇿🇦South AfricaSandoz South Africa (Pty) LtdactiveJan 1900
SANDOZ-AMOCLAV 0,6 G 20 ML🇿🇦South AfricaSandoz South Africa (Pty) LtdactiveJan 1900

Amoxycillin Sodium Equivalent To Amoxycillin in Africa — Regulatory Overview

Amoxycillin Sodium Equivalent To Amoxycillin is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 8 (73%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.